Vicenc Falco

Summary

Affiliation: Hospital Universitari Vall d'Hebron
Country: Spain

Publications

  1. ncbi request reprint Lactic acidosis related to nucleoside therapy in HIV-infected patients
    Vicenc Falco
    Infectious Diseases Division, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, P masculine Vall d Hebron 119 129 08035, Barcelona, Spain
    Expert Opin Pharmacother 4:1321-9. 2003
  2. ncbi request reprint Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Vicenc Falco
    Infectious Disease Department, Hospitals Vall d Hebron, Universitat Autonoma de Barcelona, P degrees Vall d Hebron 119 129, 08035 Barcelona, Spain
    J Antimicrob Chemother 54:481-8. 2004
  3. doi request reprint Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study
    Vicenc Falco
    Infectious Disease Department, Hospital Universitario Vall d Hebron, Barcelona, Spain
    J Acquir Immune Defic Syndr 49:26-31. 2008
  4. ncbi request reprint [Treatment for Legionnaires' disease. Macrolides or quinolones?]
    Vicenc Falco
    Servicios de Enfermedades Infecciosas, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Espana
    Enferm Infecc Microbiol Clin 24:360-4. 2006
  5. doi request reprint Emerging drugs for pneumococcal pneumonia
    Vicenc Falco
    Infectious Diseases Department, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Spain
    Expert Opin Emerg Drugs 16:459-77. 2011
  6. ncbi request reprint Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study
    Vicenc Falco
    Infectious Disease Department, Hospital Vall d Hebron, Universitat Autonoma de Barcelona, Spain
    Vaccine 24:2567-74. 2006
  7. ncbi request reprint Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy
    Queralt Jordano
    Infectious Disease Division, Hospital Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    Clin Infect Dis 38:1623-8. 2004
  8. doi request reprint Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial
    Eva Van den Eynde
    Infectious Diseases Department, Vall d Hebron Hospital, Autonomous University of Barcelona, Spain
    Clin Infect Dis 48:1152-9. 2009
  9. ncbi request reprint Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus treatment in HIV-coinfected patients
    Manuel Crespo
    Infectious Diseases Department, Hospital Universitari Vail d Hebron, Universitat Autonoma de Barcelona, Spain
    Antivir Ther 12:1217-23. 2007
  10. ncbi request reprint Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study)
    Esteban Ribera
    Infectious Diseases Service, Hospital Universitari Vall d Hebron, Barcelona, Spain
    J Acquir Immune Defic Syndr 40:317-23. 2005

Detail Information

Publications47

  1. ncbi request reprint Lactic acidosis related to nucleoside therapy in HIV-infected patients
    Vicenc Falco
    Infectious Diseases Division, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, P masculine Vall d Hebron 119 129 08035, Barcelona, Spain
    Expert Opin Pharmacother 4:1321-9. 2003
    ..Therapy is based on supportive measures and discontinuation of all antiretroviral drugs. Administration of essential vitamin coenzymes, electron acceptors and L-carnitine may be useful in some cases...
  2. ncbi request reprint Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Vicenc Falco
    Infectious Disease Department, Hospitals Vall d Hebron, Universitat Autonoma de Barcelona, P degrees Vall d Hebron 119 129, 08035 Barcelona, Spain
    J Antimicrob Chemother 54:481-8. 2004
    ..12-1 mg/L treated empirically during the first 48 h with beta-lactam antibiotics...
  3. doi request reprint Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study
    Vicenc Falco
    Infectious Disease Department, Hospital Universitario Vall d Hebron, Barcelona, Spain
    J Acquir Immune Defic Syndr 49:26-31. 2008
    ....
  4. ncbi request reprint [Treatment for Legionnaires' disease. Macrolides or quinolones?]
    Vicenc Falco
    Servicios de Enfermedades Infecciosas, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Espana
    Enferm Infecc Microbiol Clin 24:360-4. 2006
    ..Macrolides and fluoroquinolones are the recommended treatment for Legionnaires' disease. The aim of our study was to analyze the clinical efficacy of clarithromycin, azithromycin and levofloxacin in patients with Legionnaires' disease...
  5. doi request reprint Emerging drugs for pneumococcal pneumonia
    Vicenc Falco
    Infectious Diseases Department, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Spain
    Expert Opin Emerg Drugs 16:459-77. 2011
    ..However, concerns about the evolution of antibiotic resistance justify the review of new indications for known antibiotics and the development of new products...
  6. ncbi request reprint Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study
    Vicenc Falco
    Infectious Disease Department, Hospital Vall d Hebron, Universitat Autonoma de Barcelona, Spain
    Vaccine 24:2567-74. 2006
    ..In conclusion, the immunogenicity conferred by the polysaccharide vaccine in HIV-infected patients under HAART is at least as good as that observed in healthy subjects...
  7. ncbi request reprint Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy
    Queralt Jordano
    Infectious Disease Division, Hospital Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    Clin Infect Dis 38:1623-8. 2004
    ..Patients receiving trimethoprim-sulfamethoxazole (TMP-SMZ) were more likely to present with TMP-SMZ-resistant pneumococci than were those who were not receiving this agent (76.7% vs. 43.6%; P=.007). The mortality rate was high (21%)...
  8. doi request reprint Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial
    Eva Van den Eynde
    Infectious Diseases Department, Vall d Hebron Hospital, Autonomous University of Barcelona, Spain
    Clin Infect Dis 48:1152-9. 2009
    ..To study the feasibility of a response-guided therapy for chronic hepatitis C virus (HCV) infection in patients coinfected with human immunodeficiency virus (HIV) in a tertiary care hospital...
  9. ncbi request reprint Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus treatment in HIV-coinfected patients
    Manuel Crespo
    Infectious Diseases Department, Hospital Universitari Vail d Hebron, Universitat Autonoma de Barcelona, Spain
    Antivir Ther 12:1217-23. 2007
    ..Therefore, it has been suggested that monitoring RBV serum levels could be used to drive dose modification and to optimize management of HCV-infected patients receiving combination treatment...
  10. ncbi request reprint Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study)
    Esteban Ribera
    Infectious Diseases Service, Hospital Universitari Vall d Hebron, Barcelona, Spain
    J Acquir Immune Defic Syndr 40:317-23. 2005
    ....
  11. ncbi request reprint Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis
    Esteban Ribera
    Infectious Diseases Department, Hospital Universitari Vall d Hebron, Barcelona, Spain
    J Antimicrob Chemother 59:690-7. 2007
    ..To assess plasma steady-state pharmacokinetics (PK) of rifampicin, isoniazid, saquinavir and ritonavir in HIV and tuberculosis (TB) co-infected patients, and investigate potential interactions between TB drugs and protease inhibitors (PIs)...
  12. doi request reprint Raltegravir, etravirine, and ritonavir-boosted darunavir: a safe and successful rescue regimen for multidrug-resistant HIV-1 infection
    Arkaitz Imaz
    Infectious Diseases Department, Hospital Universitari Vall d Hebron and Departament de Medicina, Universidad Autonoma de Barcelona, Barcelona, Spain
    J Acquir Immune Defic Syndr 52:382-6. 2009
    ..No data from clinical trials, about this combination, are available...
  13. doi request reprint Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study)
    Esteban Ribera
    Department of Infectious Diseases, Hospital Universitari Vall d Hebron, Barcelona, Spain
    HIV Clin Trials 9:407-17. 2008
    ..Lipoatrophy is the most stigmatizing side effect of stavudine therapy. We assessed the long-term effects of replacing stavudine with tenofovir in HIV-infected patients with lipoatrophy...
  14. doi request reprint Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients
    Joaquin Burgos
    Department of Infectious Diseases, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    J Antimicrob Chemother 67:2479-86. 2012
    ..To assess the effectiveness of simplification to a dual antiretroviral regimen containing a ritonavir-boosted protease inhibitor (PI/r) in treatment-experienced HIV-1-infected patients...
  15. doi request reprint Changes in body composition and mitochondrial DNA in HIV-1-infected patients switching to fixed-dose abacavir/lamivudine or tenofovir/emtricitabine: a substudy of the BICOMBO trial
    Adrian Curran
    Infectious Diseases Department, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    Antivir Ther 17:711-8. 2012
    ....
  16. doi request reprint Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen
    Joaquin Burgos
    Department of Infectious Diseases, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    J Antimicrob Chemother 67:1453-8. 2012
    ..To assess the efficacy and safety of dual-antiretroviral therapy containing a ritonavir-boosted protease inhibitor (PI/r) in treatment-experienced patients failing a current antiretroviral regimen...
  17. doi request reprint Invasive pneumococcal disease in HIV-infected adults: clinical changes after the introduction of the pneumococcal conjugate vaccine in children
    Joaquin Burgos
    Department of Infectious Diseases, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Spain
    J Acquir Immune Defic Syndr 59:31-8. 2012
    ..We conducted a multicenter study to analyze differences in clinical presentation of IPD between HIV-infected and non-HIV-infected adults in the prevaccine and postvaccine era...
  18. pmc Ultrasensitive real-time PCR for the clinical management of visceral leishmaniasis in HIV-Infected patients
    Israel Molina
    Infectious Disease Department, Universitat Autonoma de Barcelona, Barcelona, Spain
    Am J Trop Med Hyg 89:105-10. 2013
    ..9%. Monitoring parasite load by an ultrasensitive quantitative Leishmania PCR is useful to predict the risk of relapse after a VL episode in HIV-infected patients...
  19. pmc Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain
    Fernando Salvador
    Infectious Diseases Department, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Spain
    Am J Trop Med Hyg 88:1196-202. 2013
    ..We propose a screening and management strategy of latent parasitic infections in immigrant patients infected with HIV...
  20. doi request reprint The spectrum of pneumococcal empyema in adults in the early 21st century
    Joaquin Burgos
    Infectious Diseases Department, Universitat Autonoma de Barcelona, Barcelona, Spain
    Clin Infect Dis 53:254-61. 2011
    ..Our objective was to describe the risk factors for pneumococcal empyema in adults and to analyze the differences in the incidence, disease characteristics, and serotype distribution between the pre- and post-PCV7 eras...
  21. ncbi request reprint Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients
    Manuel Crespo
    Infectious Diseases Department, Spain
    AIDS 21:477-81. 2007
    ..To investigate the utility of a week-4 virological response for sustained response prediction in hepatitis C virus (HCV) genotype 3/HIV-co-infected patients treated with interferon and ribavirin for 24 weeks...
  22. doi request reprint Impact of low-level viraemia on virological failure in HIV-1-infected patients with stable antiretroviral treatment
    Jordi Navarro
    Infectious Diseases Department, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    Antivir Ther 21:345-52. 2016
    ..Low-level viraemia (LLV) occurs in 20-40% of patients achieving viral suppression with antiretroviral therapy (ART). The risk of virological failure (VF: confirmed HIV RNA >200 copies/ml) in these patients is still a matter of debate...
  23. ncbi request reprint Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patients
    Esteban Ribera
    Infectious Diseases Service, Hospital Universitari Vall d Hebron, Barcelona, Spain
    Antivir Ther 10:605-14. 2005
    ..The purpose of this study was to evaluate the efficacy and safety of a once-daily regimen consisting of didanosine (ddI), lamivudine (3TC) and nevirapine (NVP) for adult antiretroviral-naive patients with HIV-1 infection...
  24. ncbi request reprint Management of tuberculosis in HIV-infected patients
    Adrian Curran
    Infectious Diseases Department, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    AIDS Rev 14:231-46. 2012
    ....
  25. doi request reprint Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals
    Arkaitz Imaz
    Infectious Diseases Department, Hospital Universitari Vall d Hebron, Barcelona, Spain
    J Antimicrob Chemother 66:358-62. 2011
    ..The advent of new antiretrovirals has expanded the therapeutic options for multiple drug-resistant HIV-1 infection. The role of recycled nucleoside reverse transcriptase inhibitors (NRTIs) in this scenario remains uncertain...
  26. ncbi request reprint Efficacy of recombinant interleukin-2 (rIL-2) in patients with advanced HIV-1 infection and blunted immune response to HAART
    Manuel Crespo
    Infectious Diseases Department, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Spain
    Enferm Infecc Microbiol Clin 26:27-31. 2008
    ..The primary endpoint was median change in CD4+ T-cell counts at the end of treatment as compared to baseline. Secondary endpoints were safety and changes in the various T-cell subpopulations...
  27. doi request reprint The increasing incidence of empyema
    Joaquin Burgos
    Infectious Diseases Department, Hospital Universitari Vall d Hebron, Vall d Hebron Research Institute VHIR, Universitat Autonoma de Barcelona, Spain
    Curr Opin Pulm Med 19:350-6. 2013
    ..The aim of this review is to highlight recent changes concerning the incidence of empyema. In this article we have focused on community-acquired empyema..
  28. ncbi request reprint Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome
    Carlos Pigrau
    Infectious Diseases Division, Hospital Universitari Vall d Hebron, Universitat Autonoma, Barcelona, Spain
    Am J Med 118:1287. 2005
    ..This study investigates the incidence and risk factors of infectious endocarditis in patients with pyogenic vertebral osteomyelitis, and the outcome of pyogenic vertebral osteomyelitis with and without associated infectious endocarditis...
  29. ncbi request reprint Leishmania infantum DNA detection in urine from patients with visceral leishmaniasis and after treatment control
    Roser Fisa
    Laboratory of Parasitology, Universitat de Barcelona, Barcelona, Spain
    Am J Trop Med Hyg 78:741-4. 2008
    ..This study suggests that urine-PCR is sensitive for diagnosis and may be useful to monitor treatment efficacy...
  30. doi request reprint Abacavir coadministration does not interfere with the suppressive activity of ribavirin in an HCV replicon system
    Eva Van den Eynde
    Infectious Diseases Department, Vall d Hebron Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
    Antivir Ther 16:887-93. 2011
    ..Here, we studied the effect of abacavir, tenofovir or lamivudine addition on the suppressive activity of ribavirin in an HCV RNA replicon system...
  31. doi request reprint Acute leg ischaemia in an HIV-infected patient receiving antiretroviral treatment
    Jordi Navarro
    Infectious Diseases Department, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    Antivir Ther . 2016
    ..After being interrogated he admitted taking an ergotamine-containing preparation. Ergotism due to interaction between ergotics and cobicistat was diagnosed. We describe the first reported case of this interaction...
  32. doi request reprint Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain
    Jordi Navarro
    1 Infectious Diseases Department Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    AIDS Patient Care STDS 28:537-42. 2014
    ..This strategy may help to prevent disease progression and the risk of HIV transmission in these patients...
  33. doi request reprint Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
    Joaquin Burgos
    Hospital Universitari Vall d Hebron, Vall d Hebron Research Institute VHIR, Universitat Autonoma de Barcelona, Barcelona
    Eur Respir J 43:545-53. 2014
    ..22-10.28). In conclusion, respiratory failure is a frequent complication of pneumococcal pneumonia and causes high morbidity and mortality. Pneumococcal serotypes 3, 19A and 19F are the main risk factors for this complication. ..
  34. ncbi request reprint Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study
    Maria Penaranda
    Hospital Son Dureta, Barcelona, Spain
    Clin Infect Dis 45:e82-7. 2007
    ..Our objective was to determine the effectiveness of 23-valent PPV in HIV-infected adults and the risk factors for pneumococcal pneumonia or invasive pneumococcal disease...
  35. pmc Darunavir and ritonavir total and unbound plasmatic concentrations in HIV-HCV-coinfected patients with hepatic cirrhosis compared to those in HIV-monoinfected patients
    Adrian Curran
    Hospital Vall d Hebron, Infectious Diseases Department, Universitat Autonoma de Barcelona, Barcelona, Spain Institut de Recerca Vall d Hebron, Barcelona, Spain
    Antimicrob Agents Chemother 59:6782-90. 2015
    ....
  36. doi request reprint Risk of progression to high-grade anal intraepithelial neoplasia in HIV-infected MSM
    Joaquin Burgos
    aInfectious Diseases Department bAnatomical Pathology Department, Hospital Universitari Vall d Hebron, Vall d Hebron Research Institute VHIR cInternal Medicine Department, Hospital Universitari del Mar, Universitat Autonoma de Barcelona, Spain
    AIDS 29:695-702. 2015
    ..To assess the value of several factors to predict the risk of progression to high-grade anal intraepithelial neoplasia (HGAIN) in a cohort of HIV-infected MSM...
  37. pmc Epidemiology and long-term survival in HIV-infected patients with Pneumocystis jirovecii pneumonia in the HAART era: experience in a university hospital and review of the literature
    Cristina López-Sánchez
    From the Department of Infectious Diseases CL S, VF, JB, JN, AC, LM, IO, ER, MC, BA and Department of Microbiology MTM, University Hospital Valld Hebron, Universitatautonoma de Barcelona, Barcelona, Spain
    Medicine (Baltimore) 94:e681. 2015
    ..Although the incidence has decreased, in-hospital mortality remains stable in this setting. Long-term survival is very high among HAART-adherent patients...
  38. ncbi request reprint Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone
    Joan Gavalda
    Hospital Universitari Vall d Hebron, Institut d Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain
    Ann Intern Med 146:574-9. 2007
    ..High-level aminoglycoside resistance (HLAR) that precludes bactericidal synergism with penicillins or glycopeptides and nephrotoxicity related to aminoglycoside treatment are major problems in treating Enterococcus faecalis endocarditis...
  39. ncbi request reprint Tuberculous trochanteric bursitis: report of 5 cases and literature review
    Manuel Crespo
    Hospital Universitari Vall d Hebron, Universitat Autonoma, Barcelona, Spain
    Scand J Infect Dis 36:552-8. 2004
    ..This report presents 5 new cases of TTB and a review of the literature (1981-2003), with emphasis on clinical and radiological findings and treatment, in order to investigate the optimum therapeutic approach...
  40. doi request reprint Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy
    Roger Sordé
    Department of Infectious Diseases, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Spain
    Arch Intern Med 171:166-72. 2011
    ..We assessed the usefulness of pneumococcal urinary antigen detection in the diagnosis and antimicrobial guidance in patients hospitalized with CAP...
  41. ncbi request reprint Antiretroviral salvage therapy for multiclass drug-resistant HIV-1-infected patients: from clinical trials to daily clinical practice
    Arkaitz Imaz
    HIV Unit, Infectious Diseases Department, Hospital Universitari de Bellvitge, L Hospitalet de Llobregat, Barcelona, Spain
    AIDS Rev 13:180-93. 2011
    ....
  42. ncbi request reprint Value of culture and nested polymerase chain reaction of blood in the prediction of relapses in patients co-infected with leishmania and human immunodeficiency virus
    Cristina Riera
    Laboratori de Parasitologia, Facultat de Farmacia, Universitat de Barcelona, Barcelona, Spain
    Am J Trop Med Hyg 73:1012-5. 2005
    ..However, the presence of viable parasites during post-treatment follow-up increased the probability of relapse and showed that culture positivity could be a good relapse marker...
  43. doi request reprint Restoration of T cell responses to toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitis
    Marylène Lejeune
    Immunology Service, Hospital Clinic Institut d Investigacions Biomèdiques Augustí Pi i Suñer, University of Barcelona, Barcelona, Spain
    Clin Infect Dis 52:662-70. 2011
    ..It is unknown whether a Toxoplasma gondii-specific T cell response is restored after successful combined antiretroviral therapy (cART) in patients with AIDS and current or previous toxoplasmic encephalitis (TE)...
  44. ncbi request reprint [Fever, rash, and acute respiratory failure in a young woman]
    Arkaitz Imaz
    Servicio de Enfermedades Infecciosas, Hospital General Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Enferm Infecc Microbiol Clin 26:177-8. 2008
  45. pmc Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults
    Esteban Ribera
    Servicio de Enfermedades Infecciosas, Hospital Universitari Vall d Hebron, Paseo Vall Hebron 119 129, 08035 Barcelona, Spain
    Antimicrob Agents Chemother 48:4256-62. 2004
    ....
  46. doi request reprint Investigational drugs in phase I and phase II clincial trials for the treatment of hospital-acquired pneumonia
    Vicenc Falco
    a Infectious Diseases Department, University Hospital Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
    Expert Opin Investig Drugs 25:653-65. 2016
    ..The main issue when dealing with patients with HAP and ventilator associated pneumonia (VAP) is the increasing role of multi-drug resistant organisms (MDROs)...